AAV2-GEC: Advancing Gene Delivery for Precision Treatment of Antibody-Mediated Kidney Diseases

被引：0
|
作者：
Liu, Shuya [1 ]
Wu, Guochao [1 ]
Koerbelin, Jakob [1 ]
Lu, Shun [1 ]
Huber, Tobias B. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
76.
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [21] Antibody-mediated central nervous system diseases: disease recognition and treatment challenges
    Rosenfeld, M. R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 : 30 - 32
  • [22] Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection With Intravenous Immunoglobulin
    Rapetskaya, Nadzeya
    Komissarov, Kirill
    Kalachyk, Aleh
    TRANSPLANTATION, 2022, 106 (09) : S572 - S572
  • [23] Interim Results of Proteasome Inhibition for the Treatment of Antibody-Mediated Rejection in Kidney Transplantation
    Kahn, E.
    Macaluso, M. J.
    Saggi, B. H.
    Killackey, M.
    Paramesh, A.
    Zhang, R.
    Lukitsch, I.
    Magee, J.
    Slakey, D. P.
    Buell, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 78 - 79
  • [24] Human Pooled Immunoglobulin as Treatment of Active Antibody-Mediated Rejection of Transplanted Kidney
    Furmanczyk-Zawiska, A.
    Urbanowicz, A.
    Perkowska-Ptasinska, A.
    Baczkowska, T.
    Sadowska, A.
    Nazarewski, S.
    Chmura, A.
    Durlik, M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (05) : 1446 - 1450
  • [25] New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment
    Mayer, Katharina A.
    Doberer, Konstantin
    Eskandary, Farsad
    Halloran, Philip F.
    Bohmig, Georg A.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2021, 26 (01) : 97 - 105
  • [26] Antibody-Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options
    Kim, Miae
    Martin, Spencer T.
    Townsend, Keri R.
    Gabardi, Steven
    PHARMACOTHERAPY, 2014, 34 (07): : 733 - 744
  • [27] KIDNEY ALLOGRAFT HISTOLOGIC EVOLUTION AFTER TREATMENT OF ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION
    Joly, M.
    Olagne, J.
    Parissiadis, A.
    Vargas, G. Gautier
    Cognard, N.
    Muller, C.
    Perrin, P.
    Braun, L.
    Heibel, F.
    Essayidi, A.
    Moulin, B.
    Caillard, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 19 - 19
  • [28] Imlifidase for the treatment of anti-HLA antibody-mediated processes in kidney transplantation
    Huang, Edmund
    Maldonado, Angela Q.
    Kjellman, Christian
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (03) : 691 - 697
  • [29] Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients
    Boonpheng, Boonphiphop
    De Castro, Iris Camille C.
    Ng, Yue-Harn
    Blosser, Christopher
    Bakthavatsalam, Ramasamy
    Gimferrer, Idoia
    Smith, Kelly
    Leca, Nicolae
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [30] Targeted inhibition of HBV gene expression by single chain antibody-mediated siRNA delivery
    Yang, A., Sr.
    Wen, W.
    Liu, J.
    Wang, T.
    Meng, Y.
    FEBS JOURNAL, 2007, 274 : 83 - 83
12345